Viking Therapeutics logo
Viking Therapeutics VKTX
$ 64.8 2.63%

Quarterly report 2024-Q3
added 10-23-2024

report update icon

Viking Therapeutics Operating Expenses 2011-2024 | VKTX

Annual Operating Expenses Viking Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
101 M 70.4 M 55.7 M 42.7 K 32.7 M 26.2 M 19.1 M 13.8 M 12 M - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
101 M 42.7 K 36.7 M

Quarterly Operating Expenses Viking Therapeutics

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
36.6 M 34.1 M - 27.3 M 23.7 M 20.5 M - 16.2 M 17.6 M 16.2 M - 13.4 M 15.5 M 14.2 M - 9.84 M 10.6 M 10.9 M - 7.44 M 9.57 M 6.81 M - 7.39 M 6.92 M 4.8 M - 4.69 M 4.98 M 4.97 M - 3.26 M 3.58 M 3.27 M - 4.29 M 2.63 M 461 K - 1.15 M 21.8 M 210 K - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
36.6 M 210 K 11.4 M